Skip to main content
Equibles

ARMISTICE CAPITAL, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1601086 NEW YORK, NY
Back to BMY Full portfolio

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,470,979
+$1,036,274 QoQ
Shares Held
233,790
+14.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#344
of 2,521 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $110,331,379 across 6 Drug Manufacturers - General names. BMY ranks #5 (12.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SNY
Sanofi
 1,064,000 $45,390,240
2 GRFS
Grifols SA
 2,936,000 $20,786,880
3 GSK
GSK plc
 300,000 $15,726,000
4 NVO
Novo Nordisk A S
 312,000 $14,957,280
5 BMY
Bristol Myers Squibb Co
This page 		233,790 $13,470,979
6 MDCX
Medicus Pharma Ltd.
 60,600 $0

All Filings in BMY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,470,979 233,790
2026-03-31 $12,434,705 205,024
2025-12-31 $20,090,816 372,466
2025-09-30 $29,302,958 649,733
2024-06-30 $20,385,748 490,868
2023-09-30 $30,738,738 529,613
2023-06-30 $25,580,000 400,000
2022-09-30 $42,654,000 600,000
2022-06-30 $89,012,000 1,156,000
2022-03-31 $101,949,880 1,396,000
2021-12-31 $144,901,400 2,324,000
2021-09-30 $139,404,520 2,356,000
2021-06-30 $112,123,960 1,678,000
2021-03-31 $94,695,000 1,500,000
2020-12-31 $64,263,080 1,036,000
2020-09-30 $60,290,000 1,000,000
2020-06-30 $58,800,000 1,000,000
2020-03-31 $36,119,520 648,000